Literature DB >> 3259075

Diagnosis and clinical manifestations of bacterial vaginosis.

D A Eschenbach1, S Hillier, C Critchlow, C Stevens, T DeRouen, K K Holmes.   

Abstract

Among 640 randomly selected women who were attending a sexually transmitted disease clinic and did not have trichomoniasis, 33% had bacterial vaginosis as defined by a composite of four clinical criteria: (1) Vaginal discharge was homogeneous; (2) vaginal discharge had a pH greater than or equal to 4.7; (3) vaginal discharge had an amine-like odor when mixed with 10% potassium hydroxide; (4) vaginal discharge contained clue cells representing greater than or equal to 20% of vaginal epithelial cells. Previously published Gram stain criteria for bacterial vaginosis correlated better than results of semiquantitative cultures for Gardnerella vaginalis with presence or absence of clue cells and with composite clinical criteria. Of 293 women with bacterial vaginosis by Gram stain criteria, 65% had symptoms of increased vaginal discharge and/or vaginal malodor, while 74% had signs of characteristic homogeneous vaginal discharge or amine-like odor. Elevated vaginal pH was the least specific and amine-like odor the least sensitive sign of bacterial vaginosis. Gram stain criteria for bacterial vaginosis were not associated with the concentrations of endocervical or vaginal inflammatory cells but were significantly associated with a clinical diagnosis of pelvic inflammatory disease. After adjusting for coinfection, sexual behavior, and other variables, bacterial vaginosis remained associated with adnexal tenderness (odds ratio = 9.2, p = 0.04). Bacterial vaginosis, previously implicated as a risk factor for obstetric infections, may be a risk factor for pelvic inflammatory disease.

Entities:  

Mesh:

Year:  1988        PMID: 3259075     DOI: 10.1016/0002-9378(88)90078-6

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  113 in total

1.  The communicable disease impact of eliminating publicly funded prenatal care for undocumented immigrants.

Authors:  H Kuiper; G A Richwald; H Rotblatt; S Asch
Journal:  Matern Child Health J       Date:  1999-03

Review 2.  Pelvic inflammatory disease epidemiology: what do we know and what do we need to know?

Authors:  I Simms; J M Stephenson
Journal:  Sex Transm Infect       Date:  2000-04       Impact factor: 3.519

3.  Factors linked to bacterial vaginosis in nonpregnant women.

Authors:  C Holzman; J M Leventhal; H Qiu; N M Jones; J Wang
Journal:  Am J Public Health       Date:  2001-10       Impact factor: 9.308

4.  Gynecologic Complications of Bacterial Vaginosis: Fact or Fiction?

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

5.  The development of evidence-based guidelines for over-the-counter treatment of vulvovaginal candidiasis.

Authors:  Christine M Bond; Margaret C Watson
Journal:  Pharm World Sci       Date:  2003-08

6.  DNA hybridization test: rapid diagnostic tool for excluding bacterial vaginosis in pregnant women with symptoms suggestive of infection.

Authors:  Armin Witt; Ljubomir Petricevic; Ulrike Kaufmann; Hubertus Gregor; Herbert Kiss
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

Review 7.  Gynaecological infections and strategies for treatment.

Authors:  A J Roex
Journal:  Pharm Weekbl Sci       Date:  1990-12-14

8.  New concepts in the etiology of bacterial vaginosis.

Authors:  Jane R Schwebke
Journal:  Curr Infect Dis Rep       Date:  2009-03       Impact factor: 3.725

9.  Bacterial vaginosis: prevalence in outpatients, association with some micro-organisms and laboratory indices.

Authors:  L Cristiano; N Coffetti; G Dalvai; L Lorusso; M Lorenzi
Journal:  Genitourin Med       Date:  1989-12

10.  Comparison of clinical and gram stain diagnosis methods of bacterial vaginosis among pregnant women in ethiopia.

Authors:  Zemenu Mengistie; Yimtubezinash Woldeamanuel; Daniel Asrat; Mahlet Yigeremu
Journal:  J Clin Diagn Res       Date:  2013-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.